Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy-Reference-Cited by-同舟云学术

Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy

Published:2022-04-01 Issue:4 Volume:8 Page:553
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Liu Guo-Ying¹²,Li Wang-Zhong¹,Wang De-Shen³,Liang Hu¹,Lv Xing¹,Ye Yan-Fang⁴,Zhao Chong¹,Ke Liang-Ru⁵,Lv Shu-Hui⁶,Lu Nian¹⁵,Bei Wei-Xin¹,Cai Zhuo-Chen¹,Chen Xi¹,Liang Chi-Xiong¹,Guo Xiang¹,Xia Wei-Xiong¹,Xiang Yan-Qun¹

Affiliation:

1. Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of NPC Diagnosis and Therapy, Guangzhou, China

2. Department of Radiotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

3. Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of NPC Diagnosis and Therapy, Guangzhou, China

4. Clinical Research Design Division, Sun Yat-sen Memorial Hospital, Guangzhou, China

5. Department of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of NPC Diagnosis and Therapy, Guangzhou, China

6. Medical Affairs Office, The Fifth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2789163/jamaoncology_liu_2022_oi_210104_1650482097.72288.pdf

Reference40 articles.

1. Nasopharyngeal carcinoma.;Chen;Lancet,2019

2. Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;CA Cancer J Clin,2020

3. Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy.;Li;Oncotarget,2015

4. Nasopharyngeal carcinoma: an evolving paradigm.;Wong;Nat Rev Clin Oncol,2021